Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy

Human Gene Therapy

Volumn 11, Issue 16, 2000, Pages 2219-2230

  Kuriyama, N ^a   Kuriyama, H ^a   Julin, C M ^a   Lamborn, K ^a   Israel, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COLLAGENASE; DISPASE; PROTEINASE; SOYBEAN TRYPSIN INHIBITOR; TRYPSIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INOCULATION; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; RETROVIRUS; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; BRAIN; BRAIN NEOPLASMS; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; ESCHERICHIA COLI; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; LAC OPERON; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES; TRYPSIN; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; GLYCINE MAX; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0034331161     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303400750035744     Document Type: Article

References (39)

1. Brain tumor epidemiology, growth, and invasion
2. Adeno-associated viral vectors for gene transfer and gene therapy
3. Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro
4. In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors
5. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin
6. Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents
7. Gene therapy for the hemophilias
8. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo
9. Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors
10. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery
11. Gene therapy for gliomas: p53 and E2F-1 Proteins and the target of apoptosis
12. Human adenovirus vectors for gene transfer into mammalian cells
13. Is there a future for gene therapy?
14. Adenovirus-mediated gene therapy of liver diseases
15. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential
16. Stimulation of extracellular matrix components in the normal brain by invading glioma cells
17. Delivery of an adenovirus vector in a calcium phosphate coprecipitate enhances the therapeutic index of gene transfer to airway epithelia
18. Efficacy of multiple administrations of a recombinant adenovirus expression wild-type p53 in an immune-competent mouse tumor model
19. Pre-treatment with elastase improves the efficiency of percutaneous adenovirus-mediated gene transfer to the arterial media
20. Recent advances in skeletal-muscle-based gene therapy
21. Adeno-associated virus vectors can be efficiently produced without helper virus
22. P53 tumor suppressor gene therapy for cancer
23. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins
24. Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer
25. Recombinant adenoviruses as vaccines
26. Viral vectors for gene therapy
27. Adenoviral gene transfer into the normal and injured spinal cord: Enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade
28. Restoration of tumour suppressor gene expression for cancer
29. Gene therapy for cancer: What have we done and where are we going?
30. Basics of cancer gene therapy
31. Brain extracellular matrix
32. The extracellular matrix of the central and peripheral nervous systems: Structure and function
33. Strategy of liver-directed gene therapy: Present status and future prospects
34. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology
35. The 'adenobody' approach to viral targeting: Specific and enhanced adenoviral gene delivery
36. Cytokine-modified tumor vaccines: An antitumor strategy revisited in the age of molecular medicine
37. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer
38. IL-2 gene therapy of solid tumors: An approach for the prevention of signal transduction defects in T cells